Clinical Care posts displayed by category

Pharmacist McPherson Named Visionary in Hospice and Palliative Medicine

Mary Lynn McPherson, PharmD, MA, MDE, BCPS, CPE, professor and executive director of advanced postgraduate education in palliative care in the Department of Pharmacy Practice and Science (PPS) at the University of Maryland School of Pharmacy, has been named a Visionary in Hospice and Palliative Medicine by the American Academy of Hospice and Palliative Medicine (AAHPM). She is one of 30 health care professionals, and the only pharmacist, to be honored by the organization this year in recognition of her continued work to advance the field.

“In the nearly 30 years since she joined the faculty at the School of Pharmacy, Dr. McPherson has achieved worldwide recognition as a trusted authority in the field of hospice and palliative care medicine,” says Jill A. Morgan, PharmD, BCPS, BCPPS, associate professor and chair of PPS. “She has dedicated her career not only to improving care for patients diagnosed with serious illnesses and their families as a practicing pharmacist, but also to educating future generations of practitioners to ensure that they enter the field prepared to have a marked impact on the lives of their patients. There is no one more deserving of this award, and our department congratulates her on this tremendous achievement.”

Pioneer in Palliative Care

An international expert in the field of palliative care and pain management, McPherson received her Doctor of Pharmacy (PharmD) from the school in 1986 and joined the faculty in 1990. She has maintained a practice in hospice and ambulatory care throughout her career while teaching extensively in the school’s PharmD program on pain management and end-of-life care. She established one of the first palliative care pharmacy residency programs in the United States at the school and recently launched an online, interprofessional MS in Palliative Care program for which she serves as director. She is the author of four books, including Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing, and has received numerous honors and awards for her practice and teaching throughout her career, including the Presidential Citation from the Hospice and Palliative Nurses Association and the Robert C. Chalmers Distinguished Educator Award from the American Association of Colleges of Pharmacy.

“I have had the pleasure of working with Dr. McPherson over the years on a number of educational activities, both with AAHPM and now with her recently launched MS in Palliative Care program at the School of Pharmacy,” says Vincent Jay Vanston, MD, FAAHPM, associate professor of clinical medicine at the University of Pennsylvania Perelman School of Medicine, who nominated McPherson for the award. “She is a truly outstanding teacher. Through passion, humor, and a razor-sharp mind, she engages students and draws them into her commitment to providing excellent care for patients near the end of life. More importantly, she is a genuinely kind person. She is honestly interested in her students and works assiduously to help them achieve their goals.”

Pinnacle of Success

Hospice and palliative medicine is the medical specialty that focuses on improving quality of life and relieving pain and other symptoms of seriously ill patients. AAHPM is the professional organization for physicians who specialize in this field, though members also include nurses and other health care professionals such as pharmacists, who have demonstrated a commitment to improving quality of life for seriously ill patients and their families. Its Visionaries in Hospice and Palliative Medicine awards program was established in 2012. The award is presented to deserving leaders in the field every five years based on nominations submitted by AAHPM members. From the more than 140 nominations received this year, 30 practitioners were selected as recipients.

“This program recognizes key individuals who have been critical in building and shaping our field over the past 30 years,” says Steve R. Smith, MS CAE, chief executive officer for AAHPM. “These individuals represent thousands of other health care professionals in this country who provide quality medical care and support for those living with serious illness — each and every day.”

McPherson will receive her award at the Annual Assembly of Hospice and Palliative Care in March. She and the other honorees join the inaugural group of Visionaries named by the organization in 2012.

“It is truly an honor to have been named one of this year’s Visionaries in Hospice and Palliative Medicine, particularly given the list of ‘who’s who’ nominees for this prestigious award,” McPherson says.  “I am touched that my peers thought that my work in the field to date has been of value, and receiving this recognition has invigorated me to continue my work with palliative care colleagues from across all health disciplines to further advance the role of appropriate medication management in serious illness.”

Malissa Carroll

  
Malissa Carroll Clinical Care, Education, People, UMB NewsNovember 22, 20170 comments
Read More

The President’s Message

Check out the November issue of The President’s Message. It includes Dr. Perman’s column on UMB’s outreach to alumni, a wrap-up of Founders Week, Derreck Kayongo’s Politics and Policy presentation, MPower seed grant recipients and an award for the BioPark, stories on RISING Baltimore and the schools’ Mission of Mercy community service, a safety tip, and a roundup of student, faculty, and staff achievements.

  
Chris Zang Bulletin Board, Clinical Care, Collaboration, Community Service, Contests, Education, For B'more, People, Research, Technology, UMB News, University Life, USGANovember 10, 20170 comments
Read More

‘Trauma of War’ Mask Exhibit, Luncheon, and Speaker on Nov. 20

A photo exhibit titled “Unmasking the Trauma of War” will soon be on display at the Health Sciences and Human Services Library’s (HS/HSL) Weise Gallery featuring masks that were created by military service members participating in art therapy sessions at the National Intrepid Center of Excellence (NICoE) in Bethesda, Md.

The masks explore the themes of patriotism, duality of self, and the physical and psychological pain so often experienced by our military service members.

A luncheon to kick off the exhibit featuring guest speaker Melissa Walker, MA, ATR, an art therapist and the Healing Arts Program Coordinator at NICoE, will be held Nov. 20 from noon to 1 p.m. in the Gladhill Board Room on the fifth floor of the HS/HSL. Walker will discuss the masks and show several of them at the luncheon. For more information, click here.

To attend this event, please RSVP to events@hshsl.umaryland.edu. Seating is limited.

  
Everly Brown Clinical Care, Community Service, Education, PeopleNovember 10, 20170 comments
Read More

Nursing’s Mueller-Burke and Colleagues to Assess Sedation Safety in Children

A 6-year old is experiencing a medical issue that doctors are unable to properly diagnose without ordering an MRI. On average, an MRI lasts 30 minutes to an hour and requires patients to lie completely still in a narrow, enclosed space — a tall task for a young child. In cases like these, and for other medical or dental procedures, sedation is often used to allow providers to treat children, especially those younger than 7. While sedating a child may allow for successful diagnosis and/or treatment, there are risks. According to a 2015 report in Pediatric Critical Care Medicine, approximately 5 percent of children suffer life-threatening, adverse events while sedated during a procedure.

When colleagues at the University of Maryland Medical Center (UMMC) approached Dawn Mueller-Burke, PhD ’01, MS ’98, CRNP, NNP-BC, assistant professor, University of Maryland School of Nursing (UMSON), to investigate how children undergoing procedures are being monitored for safe and adequate sedation, it was a well-matched collaboration, as Mueller-Burke had previously worked on a National Institutes of Health-funded grant regarding sedation in UMMC’s pediatric ICU.

Now, Mueller-Burke is teaming with fellow UMSON faculty member Shari Simone, DNP ’11, MS ’96, CRNP-AC, PPCNP-BC, FCCM, FAANP, assistant professor; and UMMC colleagues Peggy Dorr, DNP, CPNP, pediatric nurse practitioner, Pediatric Sedation Service, and Karen Kaiser, PhD, RN, clinical practice coordinator, Oncology, Pain, and Palliative Care, on a $14,800 UMNursing Collaborative Grant for the joint research project, “Testing Reliability, Validity and Clinical Utility of the Richmond Agitation and Sedation Scale in Spontaneously Breathing Children Undergoing a Procedure,” which they hope will prevent future sedation/agitation complications in a young population.

The Richmond Agitation and Sedation Scale (RASS) can accurately assess mechanically ventilated, sedated, pediatric critically ill patients. Mueller-Burke and the UMMC team will determine the validity, reliability, and clinical utility of RASS when used by nurses in the largest pediatric population of spontaneously breathing children to be assessed to date. Using a single tool across an institution’s care settings may reduce the risk of communication errors due to misinterpretation by providers and staff in different settings. Mueller-Burke expects the team’s findings to be applicable to a large procedural sedation population and allow description of procedural sedation patterns, both priorities of a national pediatric sedation professional organization.

“It’s great to see UMSON and UMMC nurses collaborating on a nursing project that has clear nursing outcomes. It’s really important to determine if the tools nurses use to assess children are good for the task. If they’re not, we need to adjust them or develop others,” said Erika Friedmann, PhD, professor and associate dean of research, UMSON. “This research will make a meaningful contribution to nursing practice and quality of care for vulnerable children as they undergo procedures required to diagnose and treat their health conditions.”

In addition to being exposed to sedatives during procedures more frequently than are adults, children are at risk for adverse events while receiving sedative or analgesic medications because they require a deeper level of sedation and their physiology places them at higher risk for respiratory depression and hypoxia (Cravero, et al., 2006). Although clinical judgment is important, the use of a reliable, valid, clinically useful sedation/agitation tool is critical in determining a young patient’s sedation needs. This routine assessment should minimize adverse effects associated with the sedation medications used.

“As a faculty member of the School of Nursing, I’m embracing the opportunity to work with an incredible cadre of nurse scientists and clinicians from UMMC where this idea was born. I look forward to this special opportunity as a joint collaboration between the School of Nursing and UMMC to enable multiple educational opportunities for our doctoral students,” Mueller-Burke said. “Linking arms with our fellow DNP and PhD colleagues and the bridging of academic and UMMC resources and expertise exemplifies the goal of true translation of best evidence to practice.”

 

  
Kevin Nash Bulletin Board, Clinical Care, Collaboration, Education, For B'more, People, Research, UMB News, University Life, USGANovember 6, 20170 comments
Read More

Diversity Recognition Award Nominations Sought

The President’s Diversity Advisory Council (DAC) at UMB is requesting nominations for the 2018 Dr. Martin Luther King Jr. Diversity Recognition Awards.

The awards honor individual or group achievement in the areas of diversity and inclusiveness at UMB. The recipients serve as models for the campus of personal and professional commitment to the ideals of equality, justice, and opportunity for all people epitomized by Dr. King’s life and work.

Individuals or groups will be recognized in three categories:

• Outstanding UMB faculty or unit.
• Outstanding UMB staff or unit.
• Outstanding UMB student or student group.

In addition to the underlying principles outlined above, the DAC will use the criteria on the attached nomination form when evaluating potential honorees. Those making nominations are encouraged to address as many of the criteria as appropriate. Self-nominations are acceptable.

Nominations must be received by the close of business Nov. 22, 2017.

You may submit your nominations online at the 2018 MLK Diversity Awards Nominations page.

Or, you may send nominations to:
Vanessa Fahie, PhD, RN
DAC MLK Jr. Award Committee Chair
School of Nursing
655 W. Lombard St., Room 475C
Baltimore, MD 21201

  
Vanessa Fahie Clinical Care, Collaboration, Education, For B'more, People, UMB News, University Life, USGANovember 2, 20170 comments
Read More

HS/HSL Provides Online Toolkit for Aspiring Entrepreneurs

The Health Sciences and Human Services Library (HS/HSL) has put together a toolkit of information for entrepreneurs and innovators on campus interested in learning more about intellectual property, starting a company, innovating, and other related topics.

The guide was constructed with the help of innovative individuals at UMB and is a work in progress — to be updated with future suggestions from innovators around campus who would like to contribute to the toolkit.

If you know of a resource that would make a nice addition to the toolkit, please email the HS/HSL at entre@hshsl.umaryland.edu. If you are including a web page or a website that you are directly responsible for, please include a note with permission to link to it.

  
Everly Brown Clinical Care, Collaboration, Community Service, Education, For B'more, People, Research, Technology, UMB NewsNovember 1, 20170 comments
Read More

Libraries Partner to Provide Access to ‘POLITICO Pro’

In collaboration with the Thurgood Marshall Law Library, the Health Sciences and Human Services Library (HS/HSL) has extended access to POLITICO Pro to the entire campus.

This two-year pilot offers granular reporting and analysis across 16 policy coverage areas along with tools, trackers, and data to provide users with key policy intelligence. Areas covered include education, e-health, employment and immigration, and health care.

The resource can be accessed on- and off-campus through the database list located on the HS/HSL home page or here.

  
Steven Douglas Clinical Care, Education, People, Research, TechnologyOctober 30, 20170 comments
Read More

Researcher of the Year Ernst Recounts Quest To Thwart Sepsis

Davidge Hall has been witness to some enlightening presentations over its 205 years, but chances are few foes discussed there have been more formidable than sepsis, which Robert K. “Bob” Ernst, PhD, addressed in his Founders Week Researcher of the Year presentation on Oct. 17.

A death from sepsis occurs every two minutes in the United States. Hospitals spend $23 billion on it annually, making it the most expensive condition treated in U.S. hospitals.

Ernst, professor and vice chair of the Department of Microbial Pathogenesis at the University of Maryland School of Dentistry (UMSOD), and his colleagues are engineering rationally designed mimetics based on bacterial surface molecules that will inhibit the ability of the body to mount the damaging immune response present in sepsis.

In particular, he is at the forefront of innovative research studying the molecular basis by which bacteria modify the lipid component of their membrane, specifically lipopolysaccharide (LPS), and how these alterations affect normal host innate immune system responses, potentially resulting in septic shock.

Before his presentation Ernst was saluted by University of Maryland, Baltimore President Jay A. Perman, MD, and School of Dentistry Dean Mark A. Reynolds, DDS, PhD, MA. “We recognized Dr. Ernst at the Gala Saturday night, but now he needs to work for it,” said Perman, eliciting laughter from the 100-plus Ernst colleagues, students, faculty, and staff on hand. Perman praised Ernst not only for his “groundbreaking body of work” but also as “a generous collaborator, entrepreneur, and very dedicated mentor.”

When Perman spoke of the scientist inspiring the “next generation of Bob Ernsts” an “oh, no” from the crowd brought another round of laughter, with the jovial Ernst leading the way.

Indeed, Reynolds said Ernst’s “enthusiasm for science and mentoring is contagious,” which he showed in his 45-minute presentation “Structure Matters — Making Bacterial Molecules Work for Us.”

Without notes, the award winner chronicled the journey his research has taken. He thanked a long list of collaborators and funders, saying “you can’t just rely on NIH,” which has supported Ernst and his team with $3 million in the last decade. UMB’s seed grant program and MedImmune also have provided strong support.

He discussed E coli, pattern recognition receptors, and the “bar code” in bacterial molecules. “Pathogens are detected by pattern recognition receptors on host cells that recognize structures that are broadly shared by pathogens,” Ernst said. “These bacterial patterns represent a signature or ‘bar code’ that informs the host on the level of danger of the invading organism and how to respond.”

Ernst came to UMB in the fall of 2008, moving his laboratory from the University of Washington in Seattle. David R. Goodlett, PhD, who worked closely with Ernst in Seattle studying the structure function relationships of lipid A, also came to UMB and is now a professor of pharmaceutical sciences in the University of Maryland School of Pharmacy.

In 2016, Ernst and Goodlett co-founded a startup diagnostic company called Pataigin. Last fall, the company received a $25,000 Maryland Department of Commerce Life Award for its patented test called “BACLIB” that inexpensively identifies bacteria- and fungi-causing infections in less than an hour, allowing clinicians to make decisions in the hospital at the “point-of-care.”

“Thank you to Jim Hughes and the UMB tech transfer office for all their help,” Ernst said.

When he turned to sepsis, Ernst’s tone turned more serious. “Each hour delay in antibiotic treatment the mortality rate goes up 7 percent,” he said.

Ernst admits he’s willing to talk to anyone in his quest for research advances. That approach has taken him to Maastricht in the Netherlands to utilize multimodal imaging, tracking where the blood flow is in sepsis. “They’re among the best in the world, with an image every 20 minutes instead of every three to six hours.”

Ernst was the picture of a passionate scientist, enthused and lifted when he discussed advances with E coli and the LPS, bemoaning the setbacks, praising “unheard of” assistance from the Food and Drug Administration, and recognizing his colleagues in the professional schools at UMB.

“Absolutely, this is the most collegial university that I’ve been associated with. The Department of Microbiology and Immunology in the School of Medicine and our department work together hand in glove. We are now branching out to do work with cancer researchers at UMB, MedImmune, and the National Cancer Institute, as they are also looking for novel mechanisms to attack cancer cells in the body.”

Ernst concluded his presentation with thanks to his many colleagues and a final PowerPoint slide:
Yes, structure does matter

Modulation of the host innate and adaptive immune systems
– Adjuvant development

Just the tip of the iceberg
– We are expanding our library rapidly
– We’ve neglected the carbohydrate portion – core and O-antigen

The potential for a novel antisepsis therapeutic is promising
– Inhibiting at the earliest intervention point

Asked earlier if a cure for sepsis in his lifetime is a realistic possibility, Ernst responded, “Cure, no, there will always be infections. But being able to modify the host response to give physicians a better chance to treat the symptoms associated with sepsis, potentially.”

— Chris Zang

  
Chris Zang Clinical Care, Education, People, Research, UMB NewsOctober 26, 20170 comments
Read More

Entrepreneur of the Year Griffith Revisits ‘Road To A Deep Breath’

Bartley P. Griffith, MD, took a riveted audience on the “Road to a Deep Breath” at the Entrepreneur of the Year presentation Oct. 18, one of the highlights of UMB’s Founders Week celebration.

Griffith, the Thomas E. and Alice Marie Hales Distinguished Professor in Transplant Surgery at the School of Medicine, has spent 20 years developing the world’s first wearable, artificial lung system and founded Breethe, Inc., in 2014 to perfect and commercialize it.

“There is no worse death than one from loss of lung function,” Griffith says.

To demonstrate his point, Griffith showed a PowerPoint slide of a huge rock sitting on a stick person’s chest to the audience at the BioPark Life Sciences Conference Center. It included the words “Empathy Drives Everything.”

Empathy is what has inspired Griffith in his Breethe quest. Hundreds of thousands of people die annually from lung failure. Griffith, as a surgeon who has done more than 1,250 heart transplants and 685 lung transplants, has seen firsthand the demoralizing life of those who are tied to a breathing machine in a hospital bed.

“If we build a better mousetrap, people can get up and live a more normal life, and we can get them out of the hospital,” Griffith told the audience of his original thoughts. The road wasn’t easy. There were setbacks as well as successes. “I love firsts,” says Griffith, who also was the first surgeon in America to implant a Jarvik heart in a patient and developed a pediatric heart pump.

It took decades but Griffith and his team have developed the first wearable artificial lung system. Fully portable, the pump lung unit, which is a little larger than a Coke can and sits on the patient’s belt, draws blood out down through the cannula. It oxygenates and removes carbon dioxide from the blood, which then goes back into the body. The unit also is attached to a portable pack on wheels, which contains batteries, the oxygen source, and the pump motor to control it.

“Our artificial lung device is different because of its inherently biocompatible and efficient design,” says Griffith, who also has built a resistance to clotting into it, saying “moving blood is good blood; stagnant blood is bad blood.”

With business partners Carl Cohen and Steve Orwig, who attended the presentation, and medical device executive Marshal Linder, who was out of the country, Griffith and the Breethe team are proceeding toward filing a 501(k) request for approval with the Food and Drug Administration in 2019.

Griffith, UMB’s 2010 Researcher of the Year, also credited funders like NIH and Robert Embry of the Abell Foundation, who was on hand, bioengineers like Jon Wu and Jiafeng Zhang, the UMB tech transfer office, and University leadership.

“I would be the poster boy for learning that multidisciplinary involvement is the key and the crutch that most surgical scientists have to fall upon,” said Griffith. He said the pump lung unit, which crams a surface area of 72 square meters, the size of a tennis court, into a Coke can-sized device, really is the work of the bioengineering community.

“We have passion, we have direction,” Griffth said, “but it’s that partnership between the empathetic physician that draws in the people who have the math skills to do the engineering that makes it click.”

He urged others to “innovate fearlessly” and humbly said he was just a surgeon. E. Albert Reece, MD, PhD, MBA, vice president for medical affairs at UMB and dean of the School of Medicine, disagreed in his introduction.

Said Reece: “If I had the skills to develop the perfect School of Medicine physician/scientist, that person would look highly likely like Bart Griffith. That person would be a gifted and dedicated clinician, a collaborative and determined researcher, and an innovative and visionary entrepreneur. That’s the full package, and Dr. Griffith, I believe you are the embodiment of that.”

After Griffith’s presentation, Phil Robilotto, assistant vice president in UMB’s Research and Development Tech Transfer Office, honored UMB faculty who received patents in the previous year. (See the list here).

— Chris Zang

  
Chris Zang Clinical Care, Education, People, UMB NewsOctober 26, 20170 comments
Read More

UMB is Offering a Discount on the Nissan LEAF

Thanks to the efforts of Dawn M. Rhodes, MBA, chief business and finance officer and vice president, Joe Evans, assistant vice president, and several others, UMB faculty, staff, students, and alumni have the opportunity to use a significant rebate to purchase an electric vehicle (EV), the Nissan LEAF. The Nissan program will provide a $10,000 rebate (effective until Dec. 31, 2017) on the purchase of the all-electric 2017 Nissan LEAF. This rebate can be combined with a $7,500 federal EV tax credit and a $3,000 Maryland state excise tax credit (based on the LEAF’s 30 kW/h battery), which combined with the rebate could make the purchase price of the 2017 Nissan LEAF between $12,000 and $18,000 (final price depends on the options selected).

Curious about the LEAF?

The 2017 Nissan LEAF:

  • Produces zero emissions.
  • Has a 107-mile range (as measured by the Environmental Protection Agency), which can be extended to about 123 miles in ECO mode.
  • Has an above average record for maintenance per owners as reported by Consumer Reports (based on the 2011 – 2015 models).
  • Three models are offered, the S, SV, and SL, at varying manufacturer’s suggested retail prices from $31,000 to $37,000.
  • Has excellent acceleration due to the high torque of its electric motor.
  • Can recharge in three ways: “quick charge” (80 percent charge in 30 minutes), “normal charge” (using 240 volts, 100 percent charge in 6 to 8 hours), and “trickle charge” (using 120 volts, 100 percent charge in about 26 hours). Learn more about charging the LEAF on the Nissan website.

UMB currently has 16 120-volt or 240-volt EV charging stations (serving 32 cars) spread throughout our parking garages. The Baltimore region as a whole currently provides over 200 charge station locations, and as EV popularity increases the number of charging stations is expected to increase as well.

Need a reference?

Several UMB employees already have made the switch to hybrid or electric vehicles. Laura Kozak, MA, associate vice president for Communications and Public Affairs, selected a Ford C-Max hybrid a few years ago when it was time for her to purchase a new vehicle. According to Kozak, “not having to rely solely on gas as the energy source for my commute has been great! I have a 60-mile round-trip commute so the savings have been amazing.”

I (campus architect Anthony Consoli) have been driving a hybrid car since 2004. While it’s still running great at 215,000 miles, I decided to take the plunge and go to a 100 percent EV by purchasing a Nissan LEAF, taking advantage of this rare opportunity. I’ve been driving my LEAF for a week and love it. I’m happy to be supporting a future of emission-free automotive travel.

If you’re considering a new vehicle, consider the Nissan LEAF or other EV; they help make a real difference in the health of our campus, community, and planet. For more details about the Nissan Leaf discount program, download the 2017 Nissan LEAF flyer. If you have questions about the program or charging electric vehicles on campus, please email Karen Park.

Anthony Consoli, AIA, LEED AP

  
Anthony ConsoliBulletin Board, Clinical Care, People, TechnologyOctober 12, 20171 comment
Read More

Dean Delivers State of the School of Pharmacy Address

On Sept. 11, faculty, staff, students, alumni, and officials from across the University of Maryland, Baltimore gathered in Pharmacy Hall to listen as Natalie D. Eddington, PhD, FCP, FAAPS, dean and professor of the University of Maryland School of Pharmacy, delivered her State of the School of Pharmacy Address. The address, which Eddington also presented at the Universities at Shady Grove on Sept. 6, highlighted the school’s recent accomplishments and advancements in its strategic plan areas of pharmacy education, research, practice, community engagement, and pharmapreneurship.

“Great institutions are committed to their strategic plans, and the School of Pharmacy is no exception,” Eddington said. “The latest iteration of our five-year strategic plan was implemented in 2016 and sets forth lofty goals to achieve before its conclusion in 2021. This year’s State of the School of Pharmacy Address provides an opportunity for us to reflect on those goals that we have already realized while offering a glimpse into the future at new initiatives on which we will embark in the years to come.”

Celebrating a milestone year

Eddington began her address with a recap of the School’s recent 175th anniversary celebration, which began in January 2016 and featured events attended by faculty, staff, students, alumni, and friends of the school. The 18-month celebration not only reflected on the school’s history but also highlighted its ambitions for the future, culminating in a once-in-a-lifetime event that honored nine of the school’s most extraordinary alumni as its Founding Pharmapreneurs and heralded the next era of innovation at the School – an era of pharmapreneurism.

“Our goal is to emulate and follow the example set by our nine founding pharmapreneurs, and offer our faculty, students, and staff every opportunity to be innovators of their own,” Eddington said. “Following their lead, the school will move in a direction in the years to come that no other pharmacy school in the country has conceived of – the creation of programs and initiatives focused on pharmapreneurism.”

Advancing academics

Speaking about the School’s leadership in the area of education, Eddington explained that the Doctor of Pharmacy (PharmD) program remains the largest academic program at the school, receiving an average of 1,000 applications for each class of 160 students. She also noted that the School’s two doctoral programs – the PhD in Pharmaceutical Health Services Research (PHSR) and the PhD in Pharmaceutical Sciences (PSC) – continue to attract the best and brightest students, commending the PhD in PSC program’s participation in the Meyerhoff Graduate Fellowship Program at the University of Maryland, Baltimore County, which aims to increase diversity among students pursuing doctoral degrees in biomedical and behavioral sciences. Eight graduate students currently enrolled in the program are Meyerhoff fellows.

Showcasing the expansion of the school’s academic catalog, Eddington highlighted its three online master’s degree programs – the MS in Regulatory Science, MS in Pharmacometrics, and MS in Palliative Care. Led by Mary Lynn McPherson, PharmD, MA, MDE, BCPS, CPE, professor in the Department of Pharmacy Practice (PPS) and executive director for advanced postgraduate education in palliative care at the school, the MS in Palliative Care launched in the spring of 2017 and has enrolled 80 students, including 14 physicians, 25 nurses, 11 pharmacists, six social workers, and two veterinarians. “The diverse careers held by students in the MS in Palliative Care program illustrate the truly interprofessional nature of this field and further support the demand for advanced knowledge in the field,” she said.

Breaking new ground in research

Shifting the focus to research, Eddington spotlighted the school’s integrative approach to drug discovery and development, innovative patient care, and medication outcomes and their economic impact. She reported that faculty, postdoctoral fellows, pharmacy residents, and graduate students at the school were awarded more than $28.1 million in grants and contracts during Fiscal Year 2017 – a 5 percent increase when compared to Fiscal Year 2016.

In addition to highlighting several faculty members who recently received or renewed multimillion-dollar grants with leading funding agencies such as the National Institues of Health and the National Science Foundation, Eddington presented a number of pioneering research initiatives in which the school is involved, including its participation in the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and a new partnership with the University of California, San Francisco to accelerate the pace of innovation in pediatric drug and device development.

She also explained how interdisciplinary efforts spanning the school’s three departments are helping to combat drug addiction across the nation, including efforts by researchers in PSC to develop a new opioid compound with no abuse liability, work by faculty in PPS to establish criteria for analyzing data from the state’s prescription drug monitoring program to help identify potentially harmful drug interactions and inappropriate prescribing, and initiatives led by researchers in PHSR to help shape state and federal policy surrounding prescription drug abuse and medication quality in long-term care and mental health.

“Nowhere is our focus as a comprehensive school of pharmacy more evident than in our approach to addiction,” she said. “This impressive body of work encompassing our education, research, practice, and community mission areas focuses on one of our nation’s top public health crises and demonstrates our commitment to playing a major role in curbing the dangerous trends of opioid addiction.”

Leading the pharmacy profession

In the area of practice, Eddington reported that faculty in PPS provided care for nearly 23,000 patients across Maryland in a variety of settings, including outpatient clinics, hospital units, and community pharmacies. She spotlighted the recent launch of the Applied Therapeutics, Research, and Instruction at the University of Maryland (ATRIUM) Cardiology Collaborative and congratulated Magaly Rodriguez de Bittner, PharmD, BCPS, FAPhA, professor in PPS and associate dean for clinical services and practice transformation, on being named the inaugural population health fellow with the University of Maryland Medical System, which helped pave the path for the school to partner with the medical system through a contract with its Quality Care Network to provide pharmacy services and case management support to about 125,000 patients.

Partnering with the local community

Underscoring the school’s commitment to engaging with the local community, Eddington spoke about how members of the Patient-Centered Involvement in Evaluating the Effectiveness of Treatments (PATIENTS) program, which empowers patients to ask questions about their health care concerns and actively participate in studies to answer those questions, hosted or participated in 350 community events throughout West Baltimore, reaching 1,500 patients and community members. She also applauded the work of the school’s numerous student organizations, which organized more than 70 events for members of the greater Baltimore community, noting that several of those initiatives were part of national campaigns, including the National Script Your Future Challenge, or recognized with national awards, such as the school’s American Association of Pharmaceutical Scientists student chapter receiving the organization’s 2016 Student Chapter of the Year Award.

Major charitable giving events also were spotlighted during the presentation, including the success of the school’s inaugural online Giving Day and the creation of new scholarships as a result of endowments made by the family of Felix A. Khin-Maung-Gyi, BSP ’83, PharmD, MBA, who founded and served as chair of Chesapeake Research Review before his death in 2014, and Ellen H. Yankellow, BSP ’73, PharmD ’96, president and chief executive officer of Correct Rx Pharmacy Services.

Looking toward the future

To conclude her address, Eddington offered a look into the future at the School of Pharmacy – a future made even brighter with the recent launch of its new initiative in pharmapreneurism.

“As we move into our next 175 years, the School of Pharmacy remains committed to providing our faculty, students, and staff with the tools and resources they need to solve the perennial, long-term problems facing health care, research, and society,” Eddington said. “Exclusive to the School of Pharmacy, pharmapreneurism formalizes this commitment, allowing us to focus on building innovative pharmapreneurial programs that can be incorporated into every facet of the school.”

  
Malissa Carroll Clinical Care, Community Service, Education, Research, UMB NewsSeptember 26, 20170 comments
Read More

No Pain, No Gain is the Motto for SOP’s McPherson

Since joining the faculty at the School of Pharmacy in 1990, Mary Lynn McPherson, PharmD, MA, MDE, BCPS, CPE, professor in the Department of Pharmacy Practice and Science (PPS) and executive director for advanced post-graduate education in palliative care at the school, has gained worldwide recognition for her expertise in the fields of hospice and palliative care pharmacy. Her strong showing at this year’s PAINWeek conference proved once again why her name has become synonymous with the field.

“Dr. McPherson embodies the School of Pharmacy’s mission to lead pharmacy education, scientific discovery, patient care, and community engagement across the state of Maryland and beyond,” says Jill A. Morgan, PharmD, BCPS, BCPPS, associate professor and chair of PPS. “Despite her extensive teaching commitments in the school’s Doctor of Pharmacy (PharmD) program, PGY-2 Pain and Palliative Care Residency Program, and her recently launched MS in Palliative Care program, Dr. McPherson continues to find time to make an impact in her field through research on both the national and international stage. She is a true powerhouse, and we are fortunate to have her as a member of our department.”

Held Sept. 5-9 at the Cosmopolitan of Las Vegas, PAINWeek is the largest pain conference in the United States for front-line clinicians with an interest in pain management. It is attended by more than 2,000 health care professionals each year, including physicians, physician assistants, nurse practitioners, nurses, pharmacists, hospitalists, and psychologists. While many clinicians who attend present posters and deliver talks, few can match the efforts of McPherson and her team. This year, they presented three posters and delivered eight talks highlighting their current research initiatives.

“The slogan for PAINWeek is ‘education is the best analgesic’ – a philosophy that I have embraced and operationalized since the conference’s inception nearly a decade ago,” says McPherson. “I have participated in PAINWeek each year since it was first established, and watched as participation exploded from the first 50 attendees to, now, more than 2,000 participants, all of whom are hungry for information on how to best treat pain while minimizing risk associated with the realities of practice. Pharmacists have much to contribute to the care of patients coping with pain, while upholding our responsibility to protect those individuals, prescribers, other practitioners, and society as a whole – a concept that I emphasize across all of the work that I share at this event.”

The following is a list of the posters and presentations presented by McPherson and her colleagues at this year’s event:

Posters: 

  • Mendoza K, McPherson ML. Knowledge, Skills, and Attitudes Regarding Use of Medical Cannabis in the Hospice Population: An Educational Intervention. PAINWeek 2017, Las Vegas, NV, September 2017.
  • Williams A, Sera L, McPherson ML. Anticholinergic Burden in Hospice Patients with Dementia. PAINWeek 2017, Las Vegas, NV, September 2017.
  • McPherson AL, Costantino R, Sera L, McPherson ML. Non-Prescription Medication Use in Hospice Patients. PAINWeek 2017, Las Vegas, NV, September 2017.

Presentations: 

  • McPherson ML, Gourlay D. A Comedy of Errors: Methadone, Marijuana, and Buprenorphine. PAINWeek 2017, Las Vegas, NV, September 2017.
  • McPherson ML, Ferris F, Geiger-Hayes J. Managing Pain Between a Rock and a Hard Place: Getting the Tough Jobs Done in Serious Illness. PAINWeek 2017, Las Vegas, NV, September 2017.
  • McPherson ML, Glick D. Pain Terminology: Knowing the Difference Makes a Difference. PAINWeek 2017, Las Vegas, NV, September 2017.
  • McPherson ML. Opioid Conversion Calculations. PAINWeek 2017, Las Vegas, NV, September 2017.
  • McPherson ML, Telegadis T, McPherson AL. 3’s Company: COX-2 Inhibitors, Medicinal Marijuana, and Opioid Prescribing. PAINWeek 2017, Las Vegas, NV, September 2017.
  • McPherson ML, McPherson AL. New Drug in Pain Management and Palliative Care. PAINWeek 2017, Las Vegas, NV, September 2017.
  • McPherson ML, McPherson AL. Speed Dating with the Pharmacy Ladies. PAINWeek 2017, Las Vegas, NV, September 2017.
  • McPherson ML, McPherson AL. The 411 on Nonprescription Analgesics: When to Hold ‘Em, When to Fold ‘Em. PAINWeek 2017, Las Vegas, NV, September 2017.
  
Malissa Carroll Clinical Care, PeopleSeptember 21, 20170 comments
Read More

DACA Support

In response to the announcement that the Deferred Action for Childhood Arrivals (DACA) program was being rescinded, Campus Life Services organized listening sessions to solicit feedback regarding how to move forward as a University community to support individuals who are affected directly or indirectly by this announcement. The feedback, compassion, and support toward DACA students and their families expressed in those listening sessions was palpable.

A number of excellent suggestions were provided as a result through those listening sessions. A DACA resources page is available here. Please review the information there to learn how to find help and how to get involved. This page will be updated as more information becomes available. University President Jay A. Perman, MD, has expressed his support for DACA students and their families.

Also be aware of several events:
• The Carey School of Law’s Immigration Clinic will provide free, confidential legal services to UMB students, faculty, staff, and family members for DACA renewals on Monday, Sept. 25, from 1 to 7 p.m. Register here. Individuals who currently have work authorization pursuant to the DACA program that will expire between now and March 5, 2018, may apply to renew their DACA work authorization. The deadline for filing the renewal application is Oct. 5, 2017.

Organizing for DREAMers will be held on Wednesday, Sept. 27, from noon to 1 p.m. in the SMC Campus Center Green Room. It will include both bystander and know-your-rights information, presented by CASA.

• The UMB Student Counseling Center stands ready to assist any student who is experiencing distress. Counseling services are free, and information will not be shared with anyone without your written permission. Health Sciences and Human Services Library, 4th floor, Suite 440. 410-328-8404. Contact person: Emilia K. Petrillo

  
Chris Zang Bulletin Board, Clinical Care, Collaboration, Education, People, Technology, UMB News, University Life, USGASeptember 21, 20170 comments
Read More

PSLI Orientation

Orientation for the President’s Student Leadership Institute (PSLI), a co-curricular certificate program designed to expose students to contemporary issues in leadership and professional development, will be held Sept. 26 from 1:30 to 2:30 p.m. in the SMC Campus Center. Attend this session to learn how you can fulfill the requirements and plan out the year through PSLI.

 

View MapMap and Directions | Register

Register

  
Amir ChamsazClinical CareSeptember 21, 20170 comments
Read More